In 2014, a 56‐year‐old female with a history of lobular breast carcinoma with invasive ductal component, hormone‐receptor–positive, and human epidermal growth factor receptor 2 (HER2) positive, presented with cutaneous lesions of the upper front body. This evidence concerns the gene ERBB2 and breast lobular carcinoma.